Patricia C. Briskin, NP
Nurse Practitioner · Mountain View
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 1
- 1 carrier
- Office
- 1
Offices
1 location · Sutter Bay Medical Foundation · 3,783 clinicians in this group
Looking this up.
Plans that list them
1 plan · 1 carrier
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Patricia C. Briskin’s office at (650) 691-6174 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
| Alignment Health Sutter Advantage +More (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
California Medical Board record
Licence C11311 · Deceased
Licence status: Deceased · since 1948 · Temple University School of Medicine.
Licensee is deceased.
Matched on the licence number without its letter prefix; check the name before relying on it.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Original Medicare doctor bills
$2,929
Medicare paid this office $2,929 for 158 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Anticoagulant management of patient taking warfarin | 153 | $1,921 | $9 |
Who their Medicare patients are
158 Original Medicare patients in 2024. Average age 80 · 85 and older 30% · Women 39% · Also on Medicaid 10% · Health risk score 1.55. Above the middle of the specialty; the typical nurse practitioner clinician is at 1.42.
Conditions among them: High blood pressure 75% · Atrial fibrillation 75% · Heart failure 44% · Coronary heart disease 41% · Chronic kidney disease 36% · Diabetes 28% · Cancer 16% · COPD 14% · Depression 14% · Stroke 14% · Dementia 10%.
The office billed $13,528, Medicare allowed $3,842 and paid $2,929; for 235 services of 5 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 158 | 235 | 80 | 1.55 | $13,528 | $2,929 |
| 2023 | 12 | 12 | 80 | 1.49 | $564 | $115 |
| 2022 | 141 | 247 | 81 | 1.50 | $20,926 | $1,367 |
| 2021 | 318 | 2,993 | 80 | 1.60 | $318,307 | $80,684 |
| 2020 | 272 | 2,620 | 80 | 1.98 | $270,260 | $64,431 |
| 2019 | 260 | 2,402 | 80 | 2.02 | $243,709 | $58,857 |
| 2018 | 290 | 3,102 | 79 | 1.88 | $263,825 | $66,607 |
| 2017 | 338 | 2,971 | 80 | 1.84 | $263,835 | $67,646 |
| 2016 | 363 | 2,795 | 79 | 1.70 | $229,442 | $57,417 |
| 2015 | 387 | 2,906 | 79 | 1.70 | $252,623 | $62,765 |
| 2014 | 391 | 2,838 | 78 | 1.57 | $241,407 | $60,511 |
| 2013 | 366 | 3,063 | 78 | 1.59 | $247,699 | $63,799 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 1 service
| Anticoagulant management of patient taking warfarin | 12 | $115 | $10 |
2022: 4 services
| Provision of test materials and equipment for home inr monitoring of patient with either mechanical heart valve(s), chronic atrial fibrillation, or venous thromboembolism who meets medicare coverage criteria; includes: provision of materials for use in the | 42 | $603 | $14 |
| Blood test, clotting time | 97 | $480 | $4 |
| Anticoagulant management of patient taking warfarin | 28 | $132 | $4 |
| Physician review, interpretation, and patient management of home inr testing for patient with either mechanical heart valve(s), chronic atrial fibrillation, or venous thromboembolism who meets medicare coverage criteria; testing not occurring more frequent | 45 | $97 | $2 |
2021: 6 services
| Short return visit (20+ min) | 195 | $34,244 | $69 |
| Provision of test materials and equipment for home inr monitoring of patient with either mechanical heart valve(s), chronic atrial fibrillation, or venous thromboembolism who meets medicare coverage criteria; includes: provision of materials for use in the | 66 | $30,610 | $60 |
| Blood test, clotting time | 286 | $5,234 | $4 |
| Physician review, interpretation, and patient management of home inr testing for patient with either mechanical heart valve(s), chronic atrial fibrillation, or venous thromboembolism who meets medicare coverage criteria; testing not occurring more frequent | 95 | $3,483 | $6 |
| Return visit (30+ min) | 24 | $2,671 | $107 |
| Short return visit | 53 | $2,509 | $42 |
2020: 9 services
| Short return visit (20+ min) | 177 | $29,848 | $57 |
| Provision of test materials and equipment for home inr monitoring of patient with either mechanical heart valve(s), chronic atrial fibrillation, or venous thromboembolism who meets medicare coverage criteria; includes: provision of materials for use in the | 38 | $19,654 | $61 |
| Blood test, clotting time | 249 | $5,393 | $4 |
| Return visit (30+ min) | 36 | $3,134 | $85 |
| Physician review, interpretation, and patient management of home inr testing for patient with either mechanical heart valve(s), chronic atrial fibrillation, or venous thromboembolism who meets medicare coverage criteria; testing not occurring more frequent | 56 | $2,424 | $7 |
| Short return visit | 46 | $1,673 | $29 |
| Demonstration, prior to initiation of home inr monitoring, for patient with either mechanical heart valve(s), chronic atrial fibrillation, or venous thromboembolism who meets medicare coverage criteria, under the direction of a physician; includes: face-to | 12 | $783 | $65 |
| Influenza vaccine split virus, preservative free | 12 | $732 | $61 |
| Administration of influenza virus vaccine | 14 | $293 | $21 |
2019: 6 services
| Short return visit (20+ min) | 186 | $28,995 | $54 |
| Provision of test materials and equipment for home inr monitoring of patient with either mechanical heart valve(s), chronic atrial fibrillation, or venous thromboembolism who meets medicare coverage criteria; includes: provision of materials for use in the | 28 | $17,167 | $73 |
| Blood test, clotting time | 248 | $5,448 | $4 |
| Return visit (30+ min) | 29 | $2,494 | $80 |
| Short return visit | 59 | $2,392 | $33 |
| Physician review, interpretation, and patient management of home inr testing for patient with either mechanical heart valve(s), chronic atrial fibrillation, or venous thromboembolism who meets medicare coverage criteria; testing not occurring more frequent | 29 | $1,623 | $7 |
2018: 7 services
| Short return visit (20+ min) | 206 | $32,618 | $53 |
| Provision of test materials and equipment for home inr monitoring of patient with either mechanical heart valve(s), chronic atrial fibrillation, or venous thromboembolism who meets medicare coverage criteria; includes: provision of materials for use in the | 24 | $14,718 | $91 |
| Blood test, clotting time | 274 | $7,082 | $5 |
| Anticoagulant management of patient taking warfarin | 24 | $5,814 | $9 |
| Short return visit | 72 | $3,019 | $31 |
| Return visit (30+ min) | 23 | $2,225 | $79 |
| Physician review, interpretation, and patient management of home inr testing for patient with either mechanical heart valve(s), chronic atrial fibrillation, or venous thromboembolism who meets medicare coverage criteria; testing not occurring more frequent | 24 | $305 | $6 |
2017: 6 services
| Short return visit (20+ min) | 238 | $43,192 | $55 |
| Blood test, clotting time | 320 | $9,414 | $5 |
| Provision of test materials and equipment for home inr monitoring of patient with either mechanical heart valve(s), chronic atrial fibrillation, or venous thromboembolism who meets medicare coverage criteria; includes: provision of materials for use in the | 14 | $6,819 | $118 |
| Short return visit | 80 | $3,625 | $33 |
| Return visit (30+ min) | 30 | $2,628 | $82 |
| Physician review, interpretation, and patient management of home inr testing for patient with either mechanical heart valve(s), chronic atrial fibrillation, or venous thromboembolism who meets medicare coverage criteria; testing not occurring more frequent | 65 | $1,211 | $7 |
2016: 5 services
| Short return visit (20+ min) | 264 | $41,659 | $54 |
| Blood test, clotting time | 338 | $9,251 | $5 |
| Short return visit | 74 | $3,146 | $34 |
| Return visit (30+ min) | 25 | $2,395 | $83 |
| Physician review, interpretation, and patient management of home inr testing for patient with either mechanical heart valve(s), chronic atrial fibrillation, or venous thromboembolism who meets medicare coverage criteria; testing not occurring more frequent | 66 | $949 | $7 |
2015: 6 services
| Short return visit (20+ min) | 267 | $45,497 | $54 |
| Blood test, clotting time | 363 | $9,526 | $5 |
| Short return visit | 83 | $3,480 | $33 |
| Return visit (30+ min) | 22 | $1,980 | $86 |
| New patient visit (30+ min) | 19 | $1,631 | $86 |
| Physician review, interpretation, and patient management of home inr testing for patient with either mechanical heart valve(s), chronic atrial fibrillation, or venous thromboembolism who meets medicare coverage criteria; testing not occurring more frequent | 58 | $591 | $7 |
2014: 6 services
| Short return visit (20+ min) | 272 | $42,165 | $53 |
| Blood test, clotting time | 369 | $9,016 | $5 |
| Short return visit | 137 | $5,674 | $29 |
| Return visit (30+ min) | 19 | $1,655 | $79 |
| New patient visit (30+ min) | 19 | $1,420 | $75 |
| Physician review, interpretation, and patient management of home inr testing for patient with either mechanical heart valve(s), chronic atrial fibrillation, or venous thromboembolism who meets medicare coverage criteria; testing not occurring more frequent | 41 | $502 | $7 |
2013: 6 services
| Short return visit (20+ min) | 260 | $37,182 | $52 |
| Short return visit | 200 | $12,879 | $33 |
| Blood test, clotting time | 345 | $9,072 | $5 |
| Return visit (30+ min) | 20 | $1,620 | $74 |
| New patient visit (30+ min) | 18 | $1,521 | $85 |
| Physician review, interpretation, and patient management of home inr testing for patient with either mechanical heart valve(s), chronic atrial fibrillation, or venous thromboembolism who meets medicare coverage criteria; testing not occurring more frequent | 47 | $1,316 | $7 |
Drugs they prescribed that Part D paid
$1,513
Pharmacies billed $1,513 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 57) in 2024. At or below the middle of the specialty; the typical nurse practitioner clinician is at 0%.
57 generic and 0 brand-name prescriptions · $1,513 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Warfarin | 25 | $628 | $13 |
Year by year
| 2024 | 57 | 31 | 0% (0) | 0% | $1,513 |
| 2023 | 100 | 50 | 0% (0) | None | $9,611 |
| 2022 | 378 | 164 | 0% (0) | None | $13,421 |
| 2021 | 685 | 236 | 0% (0) | 3% | $22,971 |
| 2020 | 654 | 218 | 0% (0) | 6% | $37,169 |
| 2019 | 686 | 230 | 0% (0) | 6% | $40,778 |
| 2018 | 663 | 223 | 0% (0) | 5% | $34,861 |
| 2017 | 660 | 228 | 0% (0) | 4% | $24,946 |
| 2016 | 755 | 239 | 0% (0) | None | $31,692 |
| 2015 | 622 | 211 | 0% (0) | 3% | $25,406 |
| 2014 | 612 | 202 | 0% (0) | 4% | $29,775 |
| 2013 | 663 | 193 | 0% (0) | None | $34,002 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 1 drug
| Warfarin | 93 | $2,606 | $28 |
2022: 2 drugs
| Warfarin | 353 | $9,595 | $27 |
| Jantoven | 20 | $203 | $10 |
2021: 3 drugs
| Warfarin | 627 | $15,173 | $24 |
| Enoxaparin | 30 | $3,854 | $128 |
| Jantoven | 21 | $158 | $8 |
2020: 4 drugs
| Warfarin | 576 | $17,840 | $31 |
| Eliquis | 19 | $11,581 | $610 |
| Enoxaparin | 32 | $6,875 | $215 |
| Jantoven | 18 | $187 | $10 |
2019: 5 drugs
| Warfarin | 599 | $16,656 | $28 |
| Eliquis | 13 | $12,266 | $944 |
| Enoxaparin | 26 | $5,986 | $230 |
| Coumadin | 15 | $2,615 | $174 |
| Jantoven | 24 | $353 | $15 |
2018: 4 drugs
| Warfarin | 583 | $17,571 | $30 |
| Enoxaparin | 31 | $7,507 | $242 |
| Coumadin | 17 | $2,025 | $119 |
| Jantoven | 24 | $648 | $27 |
2017: 4 drugs
| Warfarin | 601 | $16,557 | $28 |
| Enoxaparin | 23 | $5,904 | $257 |
| Coumadin | 22 | $2,171 | $99 |
| Jantoven | 12 | $253 | $21 |
2016: 4 drugs
| Warfarin | 685 | $14,908 | $22 |
| Enoxaparin | 38 | $13,824 | $364 |
| Coumadin | 18 | $2,461 | $137 |
| Jantoven | 12 | $388 | $32 |
2015: 4 drugs
| Warfarin | 557 | $14,367 | $26 |
| Enoxaparin | 21 | $7,731 | $368 |
| Coumadin | 11 | $1,076 | $98 |
| Jantoven | 27 | $351 | $13 |
2014: 3 drugs
| Enoxaparin | 28 | $14,264 | $509 |
| Warfarin | 563 | $11,325 | $20 |
| Coumadin | 16 | $4,119 | $257 |
2013: 2 drugs
| Enoxaparin | 29 | $19,252 | $664 |
| Warfarin | 624 | $13,297 | $21 |
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 84.9 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1184749715
- Licence
- CA 11311California C11311: Deceased
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Nurse practitioner (363L00000X)
- Mailing address
- 325 Distel Cir, Los Altos, CA, 94022
- NPI first listed
- 2007-03-20
- NPI last updated
- 2023-11-27
- NPI record certified
- 2023-11-27
This is when the NPI record was last certified, not a medical board exam.